
Melanocortin receptor-active peptide for neurobehavioral research.
PT-141 (Bremelanotide) is a cyclic heptapeptide agonist of MC1R, MC3R, and MC4R receptors. Investigated in neuroendocrine pathway research.
This compound is supplied strictly for in-vitro laboratory research. Not for human consumption, therapeutic, or diagnostic use.